Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy

OBJECTIVE: Tumor necrosis factor-alpha (TNF-α), checkpoint inhibitors, and interleukin-17 (IL-17) are critical targets in inflammation and autoimmune diseases. Monoclonal antibodies (mAbs) have a successful portfolio in the treatment of chronic diseases. With the current progress in stem cells and g...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallah, Ali, Estiri, Hajar, Parrish, Elizabeth, Soleimani, Mansoureh, Zeinali, Sirous, Zadeh-Vakili, Azita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722441/
https://www.ncbi.nlm.nih.gov/pubmed/31376325
http://dx.doi.org/10.22074/cellj.2020.6309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722441/
https://www.ncbi.nlm.nih.gov/pubmed/31376325
http://dx.doi.org/10.22074/cellj.2020.6309

Ejemplares similares